top of page
Backgrounds.jpg
Statesman-Examiner Logo 2025 with Shadow.png

Loading...

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Fulgent Genetics, Inc. - Common Stock (NQ:FLGT)

17.38 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, May 21, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 45
Open 17.38
Bid (Size) 15.73 (1,500)
Ask (Size) 17.51 (100)
Prev. Close 17.38
Today's Range 17.38 - 17.38
52wk Range 13.46 - 31.04
Shares Outstanding 29,926,846
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Fulgent Announces Rapid Oral Full Abstract Publication for FID-007 Within the Head and Neck Cancer Track Session at the ASCO 2026 Annual Meeting
From Fulgent Genetics, Inc.
Via Business Wire
News headline image
Lowey Dannenberg, P.C. is Investigating Fulgent Genetics Inc. (NASDAQ: FLGT) for Potential Violations of the Federal Securities Laws and Encourages Investors to Contact the Firm
From Lowey Dannenberg, P.C.
Via GlobeNewswire

Performance

YTD
-32.1%
-32.1%
1 Month
+9.0%
+9.0%
3 Month
-25.3%
-25.3%
6 Month
-39.6%
-39.6%
1 Year
-14.3%
-14.3%

More News

Read More
News headline image
Fulgent (FLGT) Q1 2026 Earnings Transcript ↗
Via The Motley Fool
Topics Earnings
Fulgent Genetics (NASDAQ:FLGT) Shares Dip Premarket After Q1 Earnings Miss Despite Revenue Beat ↗
Via Chartmill
Topics Earnings
Fulgent Genetics (NASDAQ:FLGT) Shares Plunge on Weak 2026 Outlook After Mixed Q4 ↗
Via Chartmill
News headline image
Fulgent Reports First Quarter 2026 Financial Results
From Fulgent Genetics, Inc.
Via Business Wire
News headline image
Fulgent Selected to Present Rapid Oral Abstract Within the Head and Neck Cancer Track Session at the 2026 ASCO Annual Meeting
From Fulgent Genetics, Inc.
Via Business Wire
News headline image
Lowey Dannenberg, P.C. is Investigating Fulgent Genetics Inc. (NASDAQ: FLGT) for Potential Violations of the Federal Securities Laws and Encourages Investors to Contact the Firm
From Lowey Dannenberg, P.C.
Via GlobeNewswire
News headline image
Fulgent to Announce First Quarter 2026 Financial Results on Friday, May 1, 2026
From Fulgent Genetics, Inc.
Via Business Wire
News headline image
FULGENT INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Fulgent Genetics, Inc. on Behalf of Fulgent Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
FLGT INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Fulgent Genetics Inc.
From Kirby McInerney LLP
Via Business Wire
News headline image
FLGT INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Fulgent Genetics Inc.
From Kirby McInerney LLP
Via GlobeNewswire
News headline image
FLGT SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
From Kirby McInerney LLP
Via GlobeNewswire
News headline image
FULGENT GENETICS INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud
From Kirby McInerney LLP
Via Business Wire
News headline image
Fulgent Genetics Completes Acquisition of Bako Diagnostics and StrataDx
From Fulgent Genetics, Inc.
Via Business Wire
News headline image
Lowey Dannenberg, P.C. is Investigating Fulgent Genetics Inc. (NASDAQ: FLGT) for Potential Violations of the Federal Securities Laws and Encourages Investors to Contact the Firm
From Lowey Dannenberg, P.C.
Via GlobeNewswire
News headline image
Lowey Dannenberg, P.C. is Investigating Fulgent Genetics Inc. (NASDAQ: FLGT) for Potential Violations of the Federal Securities Laws and Encourages Investors to Contact the Firm
From Lowey Dannenberg, P.C.
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGT
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fulgent Genetics, Inc. - FLGT
From Pomerantz LLP
Via GlobeNewswire
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
Via Chartmill
Which stocks are moving on Friday? ↗
Via Chartmill
Gapping stocks in Friday's session ↗
Via Chartmill
News headline image
Fulgent Genetics (FLGT) Earnings Transcript ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Fulgent Reports Fourth Quarter and Full Year 2025 Financial Results
From Fulgent Genetics, Inc.
Via Business Wire
News headline image
Fulgent to Announce Fourth Quarter and Full Year 2025 Financial Results on Friday, February 27, 2026
From Fulgent Genetics, Inc.
Via Business Wire

Frequently Asked Questions

Is Fulgent Genetics, Inc. - Common Stock publicly traded?
Yes, Fulgent Genetics, Inc. - Common Stock is publicly traded.
What exchange does Fulgent Genetics, Inc. - Common Stock trade on?
Fulgent Genetics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Fulgent Genetics, Inc. - Common Stock?
The ticker symbol for Fulgent Genetics, Inc. - Common Stock is FLGT on the Nasdaq Stock Market
What is the current price of Fulgent Genetics, Inc. - Common Stock?
The current price of Fulgent Genetics, Inc. - Common Stock is 17.38
When was Fulgent Genetics, Inc. - Common Stock last traded?
The last trade of Fulgent Genetics, Inc. - Common Stock was at 05/21/26 04:00 PM ET
What is the market capitalization of Fulgent Genetics, Inc. - Common Stock?
The market capitalization of Fulgent Genetics, Inc. - Common Stock is 520.13M
How many shares of Fulgent Genetics, Inc. - Common Stock are outstanding?
Fulgent Genetics, Inc. - Common Stock has 520M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
bottom of page